CLINICAL_TRIALS trial_result · 2021-05-13

Clinical Trial Update: Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes [Phase 2]

Phase 2 trial update for an anti-inflammatory small-molecule adjunctive therapy in type 2 diabetes shows completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Nick Giannoukakis, PhD | Conditions: Type 2 Diabetes Mellitus, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13